Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038002 (
splenomegaly
)
9,873
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Lysosomes are major sites for intracellular, acidic hydrolase-mediated proteolysis and cellular degradation. The export of low-molecular-weight catabolic end-products is facilitated by polytopic transmembrane proteins mediating secondary active or passive transport. A number of these lysosomal transporters, however, remain enigmatic. We present a detailed analysis of
MFSD1
, a hitherto uncharacterized lysosomal family member of the major facilitator superfamily.
MFSD1
is not N-glycosylated. It contains a dileucine-based sorting motif needed for its transport to lysosomes.
Mfsd1
knockout mice develop
splenomegaly
and severe liver disease. Proteomics of isolated lysosomes from
Mfsd1
knockout mice revealed GLMP as a critical accessory subunit for
MFSD1
.
MFSD1
and GLMP physically interact. GLMP is essential for the maintenance of normal levels of
MFSD1
in lysosomes and vice versa.
Glmp
knockout mice mimic the phenotype of
Mfsd1
knockout mice. Our data reveal a tightly linked
MFSD1
/GLMP lysosomal membrane protein transporter complex.
...
PMID:The lysosomal transporter MFSD1 is essential for liver homeostasis and critically depends on its accessory subunit GLMP. 3166 32